US Public Health Policy Regime Shift - Vaccine Skepticism in Leadership
Category: sovereign_debt Region: US Detected: 2026-05-18 (news window 2026-02-27)
Directional view: long_vol Actionability score: 58/100 Gap probability: 0.47
The gap (narrative vs reality)
Markets are pricing corporate operational risk from healthcare system degradation while underestimating sovereign fiscal tail risk from deliberate institutional erosion of public health infrastructure—a genuinely novel regime shift with no peacetime US precedent.
Why the system reached this view
Prosecutor identifies genuine institutional disruption with measurable behavioral impacts (Minneapolis healthcare avoidance, credit spread widening), but Defender correctly notes Treasury stability indicates markets distinguish operational from sovereign risk. The gap may exist but timing is highly uncertain—public health deterioration operates on 6-24 month lags while policy reversibility remains high given institutional opposition.
Help improve this assessment
Spot something the system missed — an event that broke the thesis, a data source it should enrich from, an adversarial angle the debate skipped? Discuss this gap (open research — your feedback shapes the next run).
Research output — not investment advice. This is the published output of an academic research system (adversarial multi-agent LLM regime detection). It is not financial advice, not a recommendation, and not a solicitation. The author is not a financial adviser. Predictions are experimental and frequently wrong. Past performance does not indicate future results. Do your own research.
Discussion & feedback
Open research — sign in with GitHub to challenge this prediction, flag a missed event, or suggest enrichment.